Combining Two Cancer Treatments for Better Results
Author Information
Author(s): Tagg S L C, Foster P A, Leese M P, Potter B V L, Reed M J, Purohit A, Newman S P
Primary Institution: Imperial College London
Hypothesis
The combination of 2-methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose will be more effective in treating breast and prostate cancer than either treatment alone.
Conclusion
The combination of STX140 and 2DG significantly inhibited tumor growth in both breast and prostate cancer models.
Supporting Evidence
- Daily administration of STX140 reduced tumor volume by 46%.
- The combination treatment reduced tumor volume by 76%.
- 2DG alone had no significant effect on tumor volume.
- The combination treatment showed similar benefits in both breast and prostate cancer models.
Takeaway
This study found that using two cancer drugs together can help shrink tumors better than using just one.
Methodology
The study used in vivo xenograft models of breast (MCF-7) and prostate (LNCaP) cancer to assess the effects of the drug combination.
Limitations
The study was conducted in animal models, which may not fully replicate human responses.
Participant Demographics
The study involved athymic nude mice, both female and male.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website